# Naseem A. Jaffrani, M.D. – FDA Inspection, Mar 13, 2025

Source: https://www.keypedia.com/records/fda_inspections/naseem-a-jaffrani-md/96752f27-f4ce-4b23-a5a2-f6468691536e
Source feed: FDA_Inspections

> FDA inspection 1263799 of Naseem A. Jaffrani, M.D., March 13, 2025. 7 citations under 21 CFR parts 50 and 312. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1263799
- Company Name: Naseem A. Jaffrani, M.D.
- Inspection Date: 2025-03-13
- Project Area: Bioresearch Monitoring: Human Drugs
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: New Orleans District Office
- Citation Count: 7

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/christopher-m-jeffers/327faaff-619a-4180-ab4c-b5f1b5ba84be)

Company: https://www.keypedia.com/companies/naseem-a-jaffrani-md/ec3be6c6-541c-4502-89ad-9e29271cfad1

Office: https://www.keypedia.com/offices/new-orleans-district-office/95352142-b992-4e06-849d-d7483c0959ea
